356.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$355.51
Aprire:
$353.17
Volume 24 ore:
1.14M
Relative Volume:
0.82
Capitalizzazione di mercato:
$69.28B
Reddito:
$321.33B
Utile/perdita netta:
$1.57B
Rapporto P/E:
44.79
EPS:
7.9518
Flusso di cassa netto:
$3.21B
1 W Prestazione:
+1.56%
1M Prestazione:
+4.42%
6M Prestazione:
+22.65%
1 anno Prestazione:
+39.72%
Cencora Inc Stock (COR) Company Profile
Nome
Cencora Inc
Settore
Industria
Telefono
610-727-7000
Indirizzo
1 WEST FIRST AVENUE, CONSHOHOCKEN
Confronta COR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
COR
Cencora Inc
|
356.14 | 69.16B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
MCK
Mckesson Corporation
|
834.18 | 102.03B | 387.09B | 4.23B | 6.01B | 32.12 |
|
CAH
Cardinal Health Inc
|
214.04 | 50.12B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
76.87 | 9.13B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.43 | 774.37M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-09-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-31 | Iniziato | Citigroup | Buy |
| 2023-01-31 | Ripresa | Evercore ISI | Outperform |
| 2022-10-11 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Ripresa | Evercore ISI | In-line |
| 2021-02-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-01-06 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Iniziato | Mizuho | Neutral |
| 2020-08-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Iniziato | Barclays | Underweight |
| 2020-06-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Ripresa | Credit Suisse | Outperform |
| 2020-04-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-02-11 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-07-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Iniziato | Guggenheim | Buy |
| 2019-04-10 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-10 | Downgrade | Jefferies | Buy → Hold |
| 2018-10-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Iniziato | Berenberg | Buy |
| 2018-07-17 | Ripresa | Stifel | Hold |
| 2018-04-09 | Iniziato | MoffettNathanson | Buy |
| 2018-03-12 | Aggiornamento | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Iniziato | JP Morgan | Neutral |
| 2017-09-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Cencora Inc Borsa (COR) Ultime notizie
8 major sponsors join Philadelphia’s FIFA World Cup lineup - The Business Journals
What to expect from Cencora's next quarterly earnings report - MSN
Market Rankings: How cyclical is HGTYs revenue stream2025 Support & Resistance & Entry Point Strategy Guides - baoquankhu1.vn
Lbp Am Sa Grows Stock Holdings in Cencora, Inc. $COR - MarketBeat
UniSuper Management Pty Ltd Boosts Stake in Cencora, Inc. $COR - MarketBeat
Cencora Stock Consolidates: Here’s Why the Stock Could Have 25% Upside - TIKR.com
Aug Update: Can Cencora Inc outperform in the next rallyJuly 2025 Institutional & Real-Time Volume Triggers - baoquankhu1.vn
Cencora, Inc. $COR Stock Position Lessened by Strs Ohio - MarketBeat
The Truth About Cencora Inc: Why Wall Street Is Quietly Obsessing Over This Healthcare Giant - AD HOC NEWS
Breakout Watch: Is Cencora Inc a cyclical or defensive stockJuly 2025 WrapUp & AI Driven Price Predictions - baoquankhu1.vn
Mitsubishi UFJ Trust & Banking Corp Raises Stock Holdings in Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Shares Sold by Teacher Retirement System of Texas - MarketBeat
Cencora, Inc. (NYSE:COR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Comparator Drug Sourcing Market to Reach USD 2.72 Billion by 2033, Driven by Rising Global Clinical Trials and Outsourcing Trends – SNS Insider - GlobeNewswire Inc.
Cencora appoints Lincoln Financial CEO Ellen Cooper to board By Investing.com - Investing.com Nigeria
Cencora CEO Mauch sells $1.8 million in shares By Investing.com - Investing.com Canada
Cencora CEO Mauch sells $1.8 million in shares - Investing.com
Insider Sell: Robert Mauch Sells Shares of Cencora Inc (COR) - GuruFocus
Jefferies Upgrades Cencora (COR) - Nasdaq
Insider Selling: Cencora (NYSE:COR) CEO Sells 5,096 Shares of Stock - MarketBeat
A Glimpse Into The Expert Outlook On Cencora Through 11 Analysts - Benzinga
Jefferies upgrades Cencora stock rating to Buy on strong execution By Investing.com - Investing.com Nigeria
Form DEF 14A Cencora, Inc. For: Mar 05 - StreetInsider
Cencora (NYSE: COR) proxy highlights $321.3B revenue, 40% TSR and board refresh - Stock Titan
Cencora Elects Ellen Cooper to Its Board of Directors - citybiz
Cencora appoints Lincoln Financial CEO Ellen Cooper to board - Investing.com
Cencora, Inc. (COR) Announces New Board Appointment - GuruFocus
Cencora (COR) Upgraded to 'Buy' by Jefferies, Price Target Raised | COR Stock News - GuruFocus
Insurance leader Ellen Cooper joins healthcare firm Cencora's board - Stock Titan
Jefferies upgrades Cencora stock rating to Buy on strong execution - Investing.com
Cencora Inc. Stock (COR) Opinions on Recent Earnings Growth - Quiver Quantitative
Rakuten Investment Management Inc. Buys New Shares in Cencora, Inc. $COR - MarketBeat
Cencora: High-Growth Specialty Services Firm Disguised As A Distributor (NYSE:COR) - Seeking Alpha
Arkadios Wealth Advisors Acquires 3,880 Shares of Cencora, Inc. $COR - MarketBeat
Triasima Portfolio Management inc. Buys Shares of 3,361 Cencora, Inc. $COR - MarketBeat
Cencora, Inc. $COR Position Reduced by Massachusetts Financial Services Co. MA - MarketBeat
Cencora, Inc. $COR Shares Bought by Dynasty Wealth Management LLC - MarketBeat
Allstate Corp Makes New Investment in Cencora, Inc. $COR - MarketBeat
If You Invested $100 In Cencora Stock 10 Years Ago, You Would Have This Much Today - Sahm
QRG Capital Management Inc. Trims Position in Cencora, Inc. $COR - MarketBeat
Amalgamated Bank Has $13.94 Million Holdings in Cencora, Inc. $COR - MarketBeat
Aug Volume: Is Cencora Inc benefiting from interest rate changesPortfolio Gains Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Wilmington Savings Fund Society FSB Purchases 3,999 Shares of Cencora, Inc. $COR - MarketBeat
Aug Spikes: What dividend growth rate does Cencora Inc offerJuly 2025 Macro Moves & Real-Time Volume Analysis - baoquankhu1.vn
Cencora Sets Date to Reveal Q1 Results as Investors Brace for Early Look - mychesco.com
Cencora Expands Credit Facilities to Finance OneOncology Deal - The Globe and Mail
Cencora Updates Multiple Financing Agreements With Major Lenders - TradingView
Cencora (NYSE: COR) expands credit lines to fund OneOncology acquisition - Stock Titan
Cencora, Inc. Enters into an Incremental Facility and Amendment Agreement - marketscreener.com
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Portfolio Recap: Is RCEL stock a good dividend stockJuly 2025 Macro Moves & Verified Trade Idea Suggestions - baoquankhu1.vn
Cencora Inc Azioni (COR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):